Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine

Autor: Adam R. Williams, Luiza Bagno, Bo Wang, Ariel Wolf, Joshua M. Hare, Mark A. Sussman, Viky Y. Loescher, Shathiyah Kulandavelu, Wayne Balkan, Julia Fritsch, Samuel Golpanian, Vasileios Karantalis, Frederic McCall, Aaron Rosenfeld, Sadia Mohsin, Azorides R. Morales, Aaron Kupin, Konstantinos E. Hatzistergos, Justin Grenet
Rok vydání: 2016
Předmět:
0301 basic medicine
Swine
Cell
Myocardial Infarction
heart failure
030204 cardiovascular system & hematology
Cardiorespiratory Medicine and Haematology
Regenerative Medicine
Cardiovascular
0302 clinical medicine
Stem Cell Research - Nonembryonic - Human
Myocardial infarction
Kinase
medicine.anatomical_structure
Heart Disease
Cardiology
Public Health and Health Services
Female
Stem Cell Research - Nonembryonic - Non-Human
Stem cell
Mitogen-Activated Protein Kinases
Cardiology and Cardiovascular Medicine
Cardiac
medicine.medical_specialty
PIM1
Placebo
Fungal Proteins
03 medical and health sciences
Rare Diseases
Internal medicine
Precursor cell
medicine
Animals
Humans
Heart Disease - Coronary Heart Disease
Myocytes
human cardiac progenitor cells
business.industry
Animal
medicine.disease
pressure volume
Stem Cell Research
030104 developmental biology
Gene Expression Regulation
injection
Cardiovascular System & Hematology
Heart failure
Disease Models
Cancer research
business
Stem Cell Transplantation
Zdroj: Journal of the American College of Cardiology, vol 68, iss 22
Popis: BackgroundPim1 kinase plays an important role in cell division, survival, and commitment of precursor cells towards a myocardial lineage, and overexpression of Pim1 in ckit+ cardiac stem cells (CSCs) enhances their cardioreparative properties.ObjectivesThe authors sought to validate the effect of Pim1-modified CSCs in a translationally relevant large animal preclinical model of myocardial infarction (MI).MethodsHuman cardiac stem cells (hCSCs, n= 10), hckit+ CSCs overexpressing Pim1 (Pim1+; n= 9), or placebo (n=10) were delivered by intramyocardial injection to immunosuppressed Yorkshire swine (n= 29) 2 weeks after MI. Cardiac magnetic resonance and pressure volume loops were obtained before and after cell administration.ResultsWhereas both hCSCs reduced MI size compared to placebo, Pim1+ cells produced a ∼3-fold greater decrease in scar mass at 8 weeks post-injection compared to hCSCs (-29.2 ± 2.7% vs.-8.4 ± 0.7%; p< 0.003). Pim1+ hCSCs alsoproduced a 2-fold increase of viable mass compared to hCSCs at 8 weeks (113.7 ± 7.2% vs. 65.6 ± 6.8%; p 
Databáze: OpenAIRE